Healthcare Services

Avian Flu Treatment Market Outlook (2026–2030): Growth Drivers and Projections

April 17, 2026April 20, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

By 2030, What Market Size Is The Avian Flu Treatment Market Expected To Reach Based On Its 2026 Value?

The avian flu treatment market has seen significant expansion in recent years. It is anticipated to expand from $13.77 billion in 2025 to $15.04 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.3%. The market’s past growth can be attributed to several factors including a rise in avian influenza outbreaks, the implementation of antiviral stockpiling strategies, government-driven disease control programs, the growth of hospital-based infectious disease treatment, and heightened public health awareness.

The avian flu treatment market is projected to experience substantial expansion in the coming years, anticipated to reach $20.6 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.2%. This growth during the projection period can be primarily attributed to heightened investments in zoonotic disease research, the escalating development of advanced vaccines, the broadening of global disease surveillance networks, an increased emphasis on rapid response therapeutics, and strengthened international cooperation for pandemic readiness. Key trends anticipated within this forecast timeframe encompass the wider adoption of advanced antiviral treatments, a sharpened focus on platforms for rapid vaccine creation, the increasing application of monoclonal antibody therapies, the broadening of early diagnosis and surveillance initiatives, and an intensified commitment to pandemic preparedness.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/avian-flu-treatment-global-market-report

What Major Factors Are Driving The Avian Flu Treatment Market Forward?

An increasing level of awareness and improved diagnostic capabilities are anticipated to fuel the expansion of the avian flu treatment market in the coming period. Awareness pertains to acknowledging a health state, whereas diagnosis involves pinpointing a particular problem subsequent to that acknowledgement. The necessity for avian flu treatment stems from the critical imperative to secure public health, avert potential widespread outbreaks, and shield poultry industries from substantial financial setbacks. Both awareness and timely diagnosis are vital for successful avian flu treatment, facilitating swift action and limiting its propagation. Illustratively, in April 2024, according to the World Health Organization (WHO), a Switzerland-based intergovernmental organization, over 8000 people in the US were actively monitored between February 9, 2022, and March 29, 2024, following exposure to animals suspected of being HPAI A (H5N1) virus-infected. Consequently, the increased awareness and diagnosis are propelling expansion within the avian flu treatment market.

How Is The Avian Flu Treatment Market Categorized Across Its Segment Groups?

The avian flu treatment market covered in this report is segmented –

1) By Type: Vaccines, Antiviral Agents, Immunoglobulins

2) By Distribution Channel: Online Pharmacies, Offline Pharmacies

3) By End User: Hospital, Institutional Health Centers, Clinics

Subsegments:

1) By Vaccines: Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Subunit Vaccines, Dna Vaccines, Bivalent And Multivalent Vaccines

2) By Antiviral Agents: Neuraminidase Inhibitors (Oseltamivir, Zanamivir), Polymerase Inhibitors, Antiviral Combination Therapies

3) By Immunoglobulins: Human Immunoglobulin (Ivig), Monoclonal Antibodies, Hyperimmune Serum, Polyvalent Immunoglobulins, Avian Flu-Specific Immunoglobulins

Which Trends Are Impacting The Progress Of The Avian Flu Treatment Market?

Leading entities in the avian flu treatment market are increasingly focusing on forging partnerships to enhance efficacy and accelerate the development of new therapies. Such collaborations involve pharmaceutical firms, research organizations, and government agencies combining resources, sharing expertise, and carrying out innovative clinical trials. For example, in April 2024, CureVac N.V., a Germany-based biotechnology company, formed a partnership with GSK plc, a UK-based pharmaceutical company, to develop an investigative influenza A (H5N1) pre-pandemic vaccine candidate aimed at addressing the potential future pandemic threat presented by the H5N1 avian influenza virus. This joint venture intends to evaluate the safety, reactogenicity, and immunogenicity of the monovalent vaccine candidate, which utilizes CureVac’s proprietary second-generation mRNA backbone to encode an influenza A H5 antigen. The combined Phase 1/2 study will assess the vaccine candidate’s safety and effectiveness in healthy adults aged 18 to 64, as well as in older adults aged 65 to 85.

Which Firms Are Influencing Competition In The Avian Flu Treatment Market?

Major companies operating in the avian flu treatment market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Sanofi S.A., GlaxoSmithKline Plc, Novartis AG, AstraZeneca Plc, Gilead Sciences Inc., CSL Limited, Moderna Inc., Shionogi & Co. Ltd., Cipla Ltd., Seqirus, Novavax Inc., Sinovac Biotech Ltd., Valneva SE, CureVac AG, BioCryst Pharmaceuticals Inc., Emergent BioSolutions Inc., Dynavax Technologies Corporation, Baxter International Inc., Takeda Pharmaceutical Company Limited

Get The Full Avian Flu Treatment Market Report:

https://www.thebusinessresearchcompany.com/report/avian-flu-treatment-global-market-report

Where Is The Avian Flu Treatment Market Most Concentrated Geographically?

North America was the largest region in the avian flu treatment market in 2025. Asia-Pacific is expected to be the fastest growing region in the market. The regions covered in the avian flu treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Avian Flu Treatment Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/avian-flu-treatment-global-market-report

Browse Through More Reports Similar to the Global Avian Flu Treatment Market 2026, By The Business Research Company

Influenza Vaccines Market Report 2026

https://www.thebusinessresearchcompany.com/report/influenza-vaccines-global-market-report

Influenza Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/influenza-treatment-global-market-report

Swine Flu Vaccination Market Report 2026

https://www.thebusinessresearchcompany.com/report/swine-flu-vaccination-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795